Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A New Viscous Cysteamine Eye Drops Treatment for Ophthalmic Cystinosis: An Open-Label Randomized Comparative Phase III Pivotal Study.

Autor: Liang H; Department of Ophthalmology III, Départment Hospitalo-Universitaire View Maintain, INSERM-DHOS, and Center of Clinical Investigations 1423, Quinze-Vingts National Ophthalmology Hospital, Institut de la Vision, Université Pierre-et-Marie-Curie University Paris 06, Paris, France., Labbé A; Department of Ophthalmology III, Départment Hospitalo-Universitaire View Maintain, INSERM-DHOS, and Center of Clinical Investigations 1423, Quinze-Vingts National Ophthalmology Hospital, Institut de la Vision, Université Pierre-et-Marie-Curie University Paris 06, Paris, France 2Department of Ophthalmology, Ambroise Paré Hospital, APHP, University of Versailles Saint-Quentin-en-Yvelines, Versailles, France., Le Mouhaër J; Orphan Europe, Medical Affairs Department, Puteaux, France., Plisson C; Orphan Europe, Medical Affairs Department, Puteaux, France., Baudouin C; Department of Ophthalmology III, Départment Hospitalo-Universitaire View Maintain, INSERM-DHOS, and Center of Clinical Investigations 1423, Quinze-Vingts National Ophthalmology Hospital, Institut de la Vision, Université Pierre-et-Marie-Curie University Paris 06, Paris, France 2Department of Ophthalmology, Ambroise Paré Hospital, APHP, University of Versailles Saint-Quentin-en-Yvelines, Versailles, France.

Publikováno v: Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2017 Apr 01; Vol. 58 (4), pp. 2275-2283.